Clinical Trial Update: 3-AP and Cytarabine in Treating Patients With Hematologic Cancer [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 trial evaluating 3-AP with cytarabine in patients with leukemia and myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• 3-AP (Triapine) (3-aminopyridine-2-carboxaldehyde thiosemicarbazone)
• CYTARABINE (CYTARABINE)

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED